COMMUNIQUÉS West-GlobeNewswire

Alpha II Will Join Health Care Leaders from Across the Globe at Cerner Health Conference 2018
04/10/2018
Healthcare conference will host nearly 14,000 in Kansas City, Oct. 8-11 TALLAHASSEE, Fla., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Alpha II, LLC , a leading developer of software-as-a-service (SaaS) solutions that support [...]
Abattis Bioceuticals Provides Phase 1 Update on Research and Development for Nanoemulsification and Liposomal Platforms of Cannabinoid-Rich Hemp Oil
04/10/2018
VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis ”) ( CSE: ATT ) ( OTC: ATTBF ) is pleased to announce that the research being done in conjunction [...]
Acasti Pharma Prices C$24 Million Underwritten Offering
04/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. LAVAL, Quebec, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST) (TSXV: ACST) (the “ Company ” or “ Acasti ”) is pleased [...]
Acasti Pharma Announces Pricing of $16.6 Million Underwritten Public Offering of Common Shares
04/10/2018
MONTREAL, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate [...]
The Ensign Group Acquires Nevada Senior Housing Facility
04/10/2018
MISSION VIEJO, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health care, hospice care [...]
BrainStorm Poster Receives Clinical Abstract Award at NEALS Conference
04/10/2018
Translational Insights Support NurOwn ® as a Best-In-Class Strategy in ALS NEW YORK and PETACH TIKVAH, Israel, Oct. 04, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of [...]
Trident Brands Inc. Signs Canadian Distribution Agreement for Their Brain Armor Brand with Peak Performance Products Inc.
04/10/2018
Brookfield, WI, Oct. 04, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Trident Brands Inc. (OTCQB:TDNT), a biotech and nutraceutical company structured to rapidly develop private label, control label, brand label and [...]
MannKind Presents Positive Afrezza® STAT Study Clinical Data at 54th Annual Meeting of the European Association for the Study of Diabetes
04/10/2018
Poster 813; PS 068 Improved post-prandial blood glucose excursions with Technosphere inhaled insulin compared to aspart in adult patients with type 1 diabetes: STAT study intention to treat analysis Poster 677; PS 051 [...]
eTrueNorth Launches National Voucher Solution Program Enabling Wellness Screenings at Retail Pharmacies
04/10/2018
Local retail pharmacies accept eLabNetwork® vouchers and provide wellness screenings FORT WORTH, Texas, Oct. 04, 2018 (GLOBE NEWSWIRE) -- e TrueNorth, the premier integrated pharmacy-based clinical services network, has [...]
Predictive Diagnostics Launches Endometriosis Risk Test
04/10/2018
SALT LAKE CITY, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC/PINK: PRED), a leader in the use of data analytics for disease identification enabling revolutionary therapeutic approaches, [...]
Adamas Announces Publication of Data Demonstrating Dyskinesia’s Impact on Activities of Daily Living in People with Parkinson’s Disease
04/10/2018
- New analysis of GOCOVRI™ (amantadine) extended release capsules pooled Phase 3 data published in Parkinsonism and Related Disorders - EMERYVILLE, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc [...]
MediPharm Labs Corp. (TSXV: LABS) (Formerly POCML 4 Inc.) Provides Corporate Update Upon Commencement of Trading on the TSXV
04/10/2018
TORONTO, Oct. 04, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (“ MediPharm Labs ” or the “ Company ”) (formerly POCML 4 Inc.; TSXV: POCM) is pleased to provide a corporate update to highlight its [...]
Assure Holdings Appoints Scott Page as an Advisor to the Board of Directors
04/10/2018
DENVER, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has appointed Scott Page as an advisor to the [...]
ALAVIDA champions self-expression and promotes “Drink Less, Your Way” campaign
04/10/2018
VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Alavida Health , a science-based virtual treatment program for heavy drinking, launched its “Drink Less, Your Way” campaign. Haber Films created the video [...]
Fluidigm Announces Agreement with DNA Software to Offer Secondary CNV Analysis for Biomark HD
04/10/2018
Combining high-performance automated microfluidics with easy-to-use software to streamline CNV detection for translational and clinical research SOUTH SAN FRANCISCO, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Fluidigm [...]
ALAVIDA champions self-expression and promotes “Drink Less, Your Way” campaign
04/10/2018
LOS ANGELES, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Alavida Health , a science-based virtual treatment program for heavy drinking, launched its “Drink Less, Your Way” campaign. Haber Films created the video that combines an [...]
Wildflower Sees 300% Growth in Online Sales This Year
04/10/2018
VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE: SUN ) (OTCQB: WLDFF ) (“Wildflower” or the "Company") is pleased to announce that it has achieved over 300% growth in online [...]
IntelGenx Partner Insud Pharma Submits ANDA for Co-Developed Generic Buccal Film Product
04/10/2018
SAINT LAURENT, Quebec, Oct. 04, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today announced that an Abbreviated New Drug Application (“ANDA”) for a generic buccal [...]
OV - Oncology Venture receives authority clearance to expand an ongoing Phase 2 study of LiPlaCis by inclusion of prostate cancer patients
04/10/2018
Hoersholm, Denmark, October 4, 2018 - Oncology Venture A/S (Nasdaq First North Stockholm: OV.ST) announces that the Danish Medicines Agency (DKMA) has approved an application to broaden the scope of an ongoing Phase 2 [...]

Pages